Erratum: Caveolin 1 is required for the activation of endothelial nitric oxide synthase in response to 17ß-estradiol (Molecular Endocrinology (2010) 24, (1637-1649) DOI: 10.1210/me.2010-0043);Caveolin 1 is required for the activation of endothelial nitric oxide synthase in response to 17β-estradiol

Molecular Endocrinology

Volumn 24, Issue 8, 2010, Pages 1637-1649

  Sud, Neetu ^a   Wiseman, Dean A ^a   Black, Stephen M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; PROTEIN KINASE B; PROTEIN KINASE P60; SERINE; SMALL INTERFERING RNA;

ADENOVIRUS; ARTICLE; BINDING SITE; CELL MEMBRANE; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELIVERY SYSTEM; GENE OVEREXPRESSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

EID: 77954968035     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0043     Document Type: Erratum

References (42)

1. Geary GG, Krause DN, Duckles SP 2000 Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms. Am J Physiol Heart Circ Physiol 279: H511-H519
2. Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA 2001 Mechanisms of estrogen action. Physiol Rev 81:1535-1565
3. McNeill AM, Kim N, Duckles SP, Krause DN, Kontos HA 1999 Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30:2186-2190 (Pubitemid 29473269)
4. Stirone C, Chu Y, Sunday L, Duckles SP, Krause DN 2003 17 β-Estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction. Eur J Pharmacol 478:35-38
5. Li H, Meininger CJ, Hawker Jr JR, Haynes TE, Kepka-Lenhart D, Mistry SK, Morris Jr SM, Wu G 2001 Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab 280:E75-E82
6. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW 2002 ERβ has nongenomic action in caveolae. Mol Endocrinol 16:938-946
7. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N, Murata Y 2001 Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 276:3459-3467
8. Chen DB, Bird IM, Zheng J, Magness RR 2004 Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 145:113-125
9. Severs NJ 1988 Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? J Cell Sci 90:341-348
10. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG 1992 Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682
11. Glenney Jr JR, Soppet D 1992 Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA 89:10517-10521
12. Okamoto T, Schlegel A, Scherer PE, Lisanti MP 1998 Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422
13. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER 2002 ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 16:100-115
14. Li S, Seitz R, Lisanti MP 1996 Phosphorylation of caveolin by src tyrosine kinases. The α-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem 271:3863-3868 (Pubitemid 126594746)
15. Stirone C, Boroujerdi A, Duckles SP, Krause DN 2005 Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol 67:105-113
16. Florian M, Lu Y, Angle M, Magder S 2004 Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids 69:637-645
17. Schlegel A, Wang C, Pestell RG, Lisanti MP 2001 Ligand-indepen- dent activation of oestrogen receptor α by caveolin-1. Biochem J 359:203-210
18. Ju H, Zou R, Venema VJ, Venema RC 1997 Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 272:18522-18525 (Pubitemid 27318186)
19. Kiss AL, Turi A, Müllner N, Kovács E, Botos E, Greger A 2005 Oestrogen-mediated tyrosine phosphorylation of caveolin-1 and its effect on the oestrogen receptor localisation: an in vivo study. Mol Cell Endocrinol 245:128-137
20. Schlegel A, Wang C, Katzenellenbogen BS, Pestell RG, Lisanti MP 1999 Caveolin-1 potentiates estrogen receptor α (ERα) signaling. caveolin-1 drives ligand-independent nuclear translocation and activation of ERα. J Biol Chem 274:33551-33556
21. Sun X, Kumar S, Tian J, Black SM 2009 Estradiol increases guanosine 5′-triphosphate cyclohydrolase expression via the nitric oxide-mediated activation of cyclic adenosine 5′-monophosphate response element binding protein. Endocrinology 150:3742-3752
22. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou Jr H, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP 2001 Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121-38138
23. Sbaa E, Frérart F, Feron O 2005 The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends Cardiovasc Med 15:157-162
24. Feron O, Kelly RA 2001 The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circ Res 88:129-131 (Pubitemid 32147297)
25. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV 2001 Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 2449-2452
26. García-Cardeña G, Oh P, Liu J, Schnitzer JE, Sessa WC 1996 Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93:6448-6453 (Pubitemid 26230326)
27. García-Cardeña G, Fan R, Stern DF, Liu J, Sessa WC 1996 Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem 271:27237-27240
28. Michel JB, Feron O, Sacks D, Michel T 1997 Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem 272:15583-15586
29. Feron O, Saldana F, Michel JB, Michel T 1998 The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem 273: 3125-3128
30. Yuhanna IS, Zhu Y, Cox BE, Hahner LD, Osborne-Lawrence S, Lu P, Marcel YL, Anderson RG, Mendelsohn ME, Hobbs HH, Shaul PW 2001 High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nat Med 7:853-857
31. Gong M, Wilson M, Kelly T, Su W, Dressman J, Kincer J, Matveev SV, Guo L, Guerin T, Li XA, Zhu W, Uittenbogaard A, Smart EJ 2003 HDL-associated estradiol stimulates endothelialNOsynthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 111: 1579-1587
32. Baillie GS, Adams DR, Bhari N, Houslay TM, Vadrevu S, Meng D, Li X, Dunlop A, Milligan G, Bolger GB, Klussmann E, Houslay MD 2007 Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of β-arrestin using spotimmobilized peptide arrays. Biochem J 404:71-80
33. Frank R 2002 The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports-principles and applications. J Immunol Methods 267:13-26
34. Kramer A, Schneider-Mergener J 1998 Synthesis and screening of peptide libraries on continuous cellulose membrane supports. Methods Mol Biol 87:25-39
35. Reineke U, Ivascu C, Schlief M, Landgraf C, Gericke S, Zahn G, Herzel H, Volkmer-Engert R, Schneider-Mergener J 2002 Identification of distinct antibody epitopes and mimotopes from a peptide array of 5520 randomly generated sequences. J Immunol Methods 267:37-51
36. Machleidt T, Li WP, Liu P, Anderson RG 2000 Multiple domains in caveolin-1 control its intracellular traffic. J Cell Biol 148:17-28 (Pubitemid 30046779)
37. Wedgwood S, Mitchell CJ, Fineman JR, Black SM 2003 Developmental differences in the shear stress-induced expression of endothelial NO synthase: changing role of AP-1. Am J Physiol Lung Cell Mol Physiol 284:L650-L662
38. Sud N, Sharma S, Wiseman DA, Harmon C, Kumar S, Venema RC, Fineman JR, Black SM 2007 Nitric oxide and superoxide generation from endothelial NOS: modulation by HSP90. Am J Physiol Lung Cell Mol Physiol 293:L1444-L1453
39. Lin MC, Almus-Jacobs F, Chen HH, Parry GC, Mackman N, Shyy JY, Chien S 1997 Shear stress induction of the tissue factor gene. J Clin Invest 99:737-744 (Pubitemid 27097677)
40. Bolte S, Cordelières FP 2006 A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213-232
41. Manders EM, Stap J, Brakenhoff GJ, van Driel R, Aten JA 1992 Dynamics of three-dimensional replication patterns during the Sphase, analysed by double labelling of DNA and confocal microscopy. J Cell Sci 103:857-862 (Pubitemid 23023255)
42. Sud N, Wells SM, Sharma S, Wiseman DA, Wilham J, Black SM 2008 Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. Am J Physiol Cell Physiol 294:C1407-C1418